Human DNA accumulates damage over time, and older people’s bodies can’t repair it as well. Many scientists believe a build up of damage can cause cells to enter an irreversible dormant state known as senescence. Cellular senescence is believed to be responsible for some of the telltale signs of aging, such as weakened bones, less resilient skin and slow-downs in organ function.
DNA damage also seems to play a role in conditions called progerias, which cause premature aging. Progeria patients have mutations in genes responsible for DNA damage repair. Now researchers from the University of Pennsylvania have pinpointed a molecular link between DNA damage, cellular senescence and premature aging. The team state that finding the key players could lead to therapeutic targets for counteracting some of the negative effects of progerias and perhaps even forestalling the effects of natural aging.
The opensource study, published in the journal Cell Reports, took a closer look at the chemical messenger interferon, a molecule that is naturally produced by the body in response to invading pathogens such as viruses. The team found that interferon signaling ramps up in response to double-stranded DNA breaks and that this signaling prompts cells to enter senescence.
When the researchers inactivated the interferon signaling pathways in a mouse model of progeria, however, they were able to extend the animals’ lives. These mice were more fertile, had less gray hair and were larger and more robust than animals in which the interferon pathway was still active. The data findings imply that some of the effects of DNA damage could be managed by perhaps locally blocking interferon signaling.
Though the main role of interferon is to help cells respond to pathogens the team began considering a growing body of evidence linking interferon to DNA damage. Previous studies had shown that people with autoimmune diseases characterized by up-regulated interferon signaling also had a build-up of DNA strand breaks. And cancer treatments such as chemotherapy and radiation, which cause DNA damage, also lead to increased interferon signaling.
It is known that if you add a DNA-damaging agent in a high enough concentration, you will trigger interferon production. However, the researchers didn’t know whether it was the DNA damage itself that led to the interferon induction or if some other aspect of the cells being killed led to the induction. The current study first examined the effect of DNA damage on interferon signaling. Using an experimental technique that the lab had earlier developed that creates double-stranded breaks in DNA without chemotherapies or radiation, the researchers found that levels of the interferon protein IFNβ and a reporter molecule tied to interferon production, IRF7, both rose.
The team also found significantly higher levels of IFNβ expression in the older cells from human patients with progerias and also in mice with a mutation that causes a progeria-like condition. Using a drug that blocks IFNβ caused fewer cells to enter senescence, suggesting that senescence was triggered by DNA-damage-induced interferon signaling.
The team explain that one of the reasons senescence is believed to lead to the characteristic changes of aging is that it affects stem cells, which normally serve to replenish populations of healthy cells. Earlier studies had shown that mice lacking the Terc gene, which is key to DNA repair, have lower stem cell function and age prematurely, losing fertility and developing scaly skin, gray fur and shrunken, hunched bodies. These mice also have abnormalities in their intestinal tissues, a site known to be greatly affected by stem cell failure.
As a final in vivo test the researchers bred Terc-deficient mice to animals also lacking an interferon receptor. These animals had reduced signs of premature aging; they were more fertile, had less gray hair, were larger and lived longer on average than mice lacking only Terc. The data findings showed that the majority of these phenotypes could be rescued by abolishing interferon signaling, showing that there is a substantial role of interferon in aging that is caused by persistent DNA damage.
For people who suffer from the effects of accelerated aging after undergoing treatments such as radiation that damage DNA or who suffer from acute radiation poisoning these findings hint at novel therapies state the team, adding that, perhaps their problems could be alleviated if interferon was neutralized locally.
While the current study doesn’t pertain directly to normal aging in healthy individuals the researchers state that future studies could shed light on ways to mitigate its negative effects. The team explain since natural aging is connected with the DNA damage accumulated over a lifetime and with decline in the stem cell functions, the skin is not repairing as well, bones are not holding as well as they used to. There is rationale for the future studies on the role of interferon in normal aging and it’s ‘protective’ nature.
The team surmise that the role of interferon works at different levels. For a single cell, by protecting it from viruses that can change its genetic information; for a multi-cellular organism, by preventing genetically altered cells from proliferating via senescence; and for a society, by decreasing fertility of individuals carrying damaged genomic material.
Source: University of Pennsylvania
aging, autoimmune disease, Cellular senescence, DNA damage, DNA repair, epigenetics, genetics, healthinnovations, immunology, opensource, precision medicine, premature aging, Progeria, regenerative medicine, stem cell
Michelle is a health industry veteran who taught and worked in the field before training as a science journalist.
Featured by numerous prestigious brands and publishers, she specializes in clinical trial innovation--expertise she gained while working in multiple positions within the private sector, the NHS, and Oxford University.